Disclosed are compounds of formula (I):
and pharmaceutically acceptable N-oxides, salts, hydrates, solvates, complexes, bioisosteres, metabolites, and prodrugs thereof, which are of use in the treatment of infection with, and diseases caused by,
Clostridium difficile.
本发明涉及式(I)化合物及其药学上可接受的N-氧化物、盐、
水合物、溶剂合物、复合物、
生物等构效类似物、代谢物和前药,这些化合物可用于治疗由Clostridium difficile感染引起的疾病。